HK1157190A1 - Isolated renal cells and uses thereof - Google Patents

Isolated renal cells and uses thereof

Info

Publication number
HK1157190A1
HK1157190A1 HK11111451.6A HK11111451A HK1157190A1 HK 1157190 A1 HK1157190 A1 HK 1157190A1 HK 11111451 A HK11111451 A HK 11111451A HK 1157190 A1 HK1157190 A1 HK 1157190A1
Authority
HK
Hong Kong
Prior art keywords
renal cells
isolated renal
methods
cell populations
isolated
Prior art date
Application number
HK11111451.6A
Other languages
English (en)
Inventor
Sharon Presnell
Andrew Bruce
Shay M Wallace
Sumana Choudhury
Russell W Kelley
Manuel J Jayo
Eric S Werdin
Patricia D Tatsumi
Jessica J Reinsch
Timothy A Bertram
Oluwatoyin A Knight
H Scott Rapoport
Roger M Ilagan
Original Assignee
Tengion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tengion Inc filed Critical Tengion Inc
Publication of HK1157190A1 publication Critical patent/HK1157190A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/14—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK11111451.6A 2008-11-12 2011-10-25 Isolated renal cells and uses thereof HK1157190A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US11403008P 2008-11-12 2008-11-12
US11402508P 2008-11-12 2008-11-12
US20105608P 2008-12-05 2008-12-05
US20130508P 2008-12-08 2008-12-08
US12131108P 2008-12-10 2008-12-10
PCT/US2009/006085 WO2010056328A1 (en) 2008-11-12 2009-11-12 Isolated renal cells and uses thereof

Publications (1)

Publication Number Publication Date
HK1157190A1 true HK1157190A1 (en) 2012-06-29

Family

ID=41625133

Family Applications (2)

Application Number Title Priority Date Filing Date
HK11111451.6A HK1157190A1 (en) 2008-11-12 2011-10-25 Isolated renal cells and uses thereof
HK14110826A HK1197267A1 (zh) 2008-11-12 2014-10-29 分離的腎細胞及其用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK14110826A HK1197267A1 (zh) 2008-11-12 2014-10-29 分離的腎細胞及其用途

Country Status (10)

Country Link
US (5) US8318484B2 (zh)
EP (3) EP3388509A1 (zh)
JP (5) JP5974233B2 (zh)
KR (4) KR102357077B1 (zh)
CN (2) CN102271692B (zh)
AU (5) AU2009314552B2 (zh)
CA (1) CA2743459A1 (zh)
HK (2) HK1157190A1 (zh)
NZ (2) NZ601862A (zh)
WO (1) WO2010056328A1 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008262333B2 (en) 2007-06-08 2014-07-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
US10590391B2 (en) 2007-06-08 2020-03-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
CA2780320A1 (en) 2009-11-12 2011-05-19 Tengion, Inc. Rational design of regenerative medicine products
EP2569418B1 (en) * 2010-05-12 2016-11-02 RegenMed (Cayman) Ltd. Bioactive renal cells
KR101913874B1 (ko) * 2010-11-10 2018-10-31 인리젠 장기 확대를 위한 주사가능 제제
EP3425391A1 (en) 2011-11-04 2019-01-09 inRegen Drug screening and potency assays
WO2014066699A1 (en) 2012-10-24 2014-05-01 Tengion, Inc. Renal cell populations and uses thereof
JP6509745B2 (ja) * 2013-01-25 2019-05-08 エックスセル・バイオサイエンシズ・インコーポレイテッド 標的細胞の選択的富化のための方法、組成物、キット、及びシステム
BR112015027996A8 (pt) 2013-05-08 2017-09-26 Regenmedtx Llc Organoides compreendendo células renais isoladas e suas utilizações
NZ741539A (en) 2015-11-06 2024-03-22 Ventana Med Syst Inc Representative diagnostics
CN109890397A (zh) * 2016-07-29 2019-06-14 迪帕克.简 用于治疗慢性肾病的生物活性肾细胞
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
CN111182921A (zh) * 2017-06-21 2020-05-19 蒂莫西.A.伯特伦 用于治疗肾疾病的免疫豁免的生物活性肾细胞
CN108251352B (zh) * 2018-02-01 2021-07-06 伯仕利生物科技发展（盐城）有限公司 一种血管内皮干细胞的培养方法
WO2021177387A1 (ja) * 2020-03-04 2021-09-10 株式会社メトセラ エリスロポエチン産生能が亢進された線維芽細胞
WO2021176420A1 (en) 2020-03-06 2021-09-10 ReGenesys BVBA Biocompatible scaffolds for culturing post natal progenitor cells
CN112107600B (zh) * 2020-10-26 2024-04-05 张哲� 一种治疗色素沉着性疾病的纳米制剂及其制备方法
CN114703120B (zh) * 2022-03-17 2024-02-02 上海纽仁生物医药科技有限公司 一种动物神经系统血管平滑肌细胞单细胞的分离方法
CN114507642B (zh) * 2022-03-17 2024-02-02 上海纽仁生物医药科技有限公司 一种动物神经系统周细胞单细胞的分离方法
WO2024006918A2 (en) * 2022-06-29 2024-01-04 Prakash Narayan Selected renal cell populations, characteristics and uses thereof

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045849B2 (ja) * 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5032508A (en) 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US4769037A (en) * 1986-10-28 1988-09-06 Midcalf Robert J Artificial replacement kidney implant and method of dialyzing blood
GB8722854D0 (en) * 1987-09-29 1987-11-04 Hardy S M Implantable artificial kidney
US5085629A (en) * 1988-10-06 1992-02-04 Medical Engineering Corporation Biodegradable stent
CN1053698C (zh) 1989-01-19 2000-06-21 南京大学 细胞培养生产促红细胞生成素的方法
DE69017820T2 (de) 1989-04-25 1995-10-05 Childrens Medical Center Implantaten für grosse mengen von zellen auf polymerische matrizen.
US4996154A (en) * 1989-05-04 1991-02-26 Millipore Corporation Method for growing cellular tissue
AU2900792A (en) 1991-10-24 1993-05-21 Children's Medical Center Corporation Neomorphogenesis of urological structures in vivo from cell culture
PT101031B (pt) * 1991-11-05 2002-07-31 Transkaryotic Therapies Inc Processo para o fornecimento de proteinas por terapia genetica
US5549674A (en) * 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US5429938A (en) * 1992-03-02 1995-07-04 University Of Michigan Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
US6060270A (en) * 1992-03-02 2000-05-09 The University Of Michigan Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
US6410320B1 (en) * 1992-03-02 2002-06-25 The University Of Michigan Method and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
US5545131A (en) * 1994-04-28 1996-08-13 White Eagle International Technologies, Lp Artificial kidney
US6673339B1 (en) * 1996-09-05 2004-01-06 Children's Medical Center Corporation Prosthetic kidney and its use for treating kidney disease
DE69727817T2 (de) * 1996-09-05 2005-01-05 Children's Medical Center Corp., Boston Nierenprothese und ihre Verwendung zum Behandeln einer Nierenkrankheit
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
GB2335127B (en) * 1996-12-19 2002-02-13 Hyundai Electronics America Video frame rendering engine
US5854006A (en) * 1997-03-28 1998-12-29 The University Of Virginia Gamma-glutamyl transpeptidase-specific antibody, prodrugs for the treatment of gamma-glutamyl transpeptidase-expressing tumors, and methods of administration thereof
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
JP2004155788A (ja) * 1998-09-24 2004-06-03 Tanabe Seiyaku Co Ltd 腎疾患治療薬およびそのスクリーニング方法
US6777205B1 (en) * 1998-11-06 2004-08-17 Sterrenbeld Biotechnologie North America, Inc. Host cells expressing recombinant human erythropoietin
MXPA01011429A (es) * 1999-05-11 2003-09-10 Ortho Mcneil Pharm Inc Modelado farmacocinetico y farmacodinamico de administracion de eritropoyetina.
US20040167634A1 (en) * 1999-05-26 2004-08-26 Anthony Atala Prosthetic kidney and its use for treating kidney disease
AU3195700A (en) 1999-05-27 2000-12-18 Tanabe Seiyaku Co., Ltd. Remedies for kidney diseases and method for screening the same
KR100369788B1 (ko) 1999-09-03 2003-01-29 동아제약 주식회사 재조합 인간 에리트로포이에틴의 제조방법
US6376244B1 (en) * 1999-12-29 2002-04-23 Children's Medical Center Corporation Methods and compositions for organ decellularization
US7326570B2 (en) * 2000-06-16 2008-02-05 The Regents Of The University Of California Induction of tubular morphogenesis using pleiotrophin
US6548081B2 (en) * 2000-07-28 2003-04-15 Anika Therapeutics, Inc. Bioabsorbable composites of derivatized hyaluronic acid and other biodegradable, biocompatible polymers
DK1355655T5 (da) * 2000-10-30 2007-08-13 Zymogenetics Inc Præparater og fremgangsmåder til forbedring af nyrefunktion
WO2002061053A1 (en) 2001-01-31 2002-08-08 The General Hospital Corporation Renal stem cells and uses thereof
JPWO2002101029A1 (ja) * 2001-05-31 2004-09-24 旭化成株式会社 腎再生用細胞の分離濃縮方法
US6784154B2 (en) * 2001-11-01 2004-08-31 University Of Utah Research Foundation Method of use of erythropoietin to treat ischemic acute renal failure
EP2292278B1 (en) * 2001-11-16 2013-04-24 Children's Medical Center Corporation Augmentation of organ function
US20030180268A1 (en) * 2002-02-05 2003-09-25 Anthony Atala Tissue engineered construct for supplementing or replacing a damaged organ
EP1491187A4 (en) 2002-03-22 2008-04-16 Kissei Pharmaceutical PREVENTIVE OR THERAPEUTIC AGENT FOR RENAL DISEASES
CA2521979A1 (en) * 2003-04-09 2004-10-28 University Of Utah Research Foundation Compositions and methods related to production of erythropoietin
US20060153894A1 (en) 2004-06-30 2006-07-13 Ragae Ghabrial Multi-compartment delivery system
AU2006292203A1 (en) 2005-09-21 2007-03-29 Dask Technologies, Llc Methods and compositions for organ and tissue functionality
CN102389344B (zh) * 2006-02-07 2015-12-16 脊柱赛特有限公司 采用机械应变使人皮肤成纤维细胞发生软骨形成分化的方法
JP5416415B2 (ja) 2006-02-10 2014-02-12 テンジオン， インコーポレイテッド 臓器の再建および増強のための骨格
JPWO2007125916A1 (ja) 2006-04-24 2009-09-10 株式会社ステムセル研究所 移植用臓器の調製方法
ES2432395T3 (es) * 2006-10-12 2013-12-03 Ethicon, Inc. Células derivadas de riñon y metodo de uso en la reparación y regeneración tisular
WO2008061213A2 (en) 2006-11-16 2008-05-22 Genentech, Inc. Genetic variations associated with tumors
US20110008347A1 (en) 2006-12-01 2011-01-13 Agency For Science ,Technology And Research Cancer-related protein kinases
US10590391B2 (en) * 2007-06-08 2020-03-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
AU2008262333B2 (en) 2007-06-08 2014-07-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
WO2010057015A1 (en) 2008-11-14 2010-05-20 Wake Forest University Health Sciences Kidney structures and methods of forming the same
JP5565607B2 (ja) 2009-07-15 2014-08-06 国立大学法人 東京大学 敗血症又は多臓器不全の予後診断方法及び予後診断用キット

Also Published As

Publication number Publication date
AU2017202897B2 (en) 2019-04-18
CN102271692A (zh) 2011-12-07
US20110117162A1 (en) 2011-05-19
AU2020239736A1 (en) 2020-10-15
EP3388509A1 (en) 2018-10-17
AU2020239736B2 (en) 2024-02-08
US20160206659A1 (en) 2016-07-21
AU2009314552B2 (en) 2017-02-02
US20190117695A1 (en) 2019-04-25
AU2024203036A1 (en) 2024-05-30
JP2018148909A (ja) 2018-09-27
EP2358375B1 (en) 2013-07-24
KR102428795B1 (ko) 2022-08-04
WO2010056328A1 (en) 2010-05-20
CA2743459A1 (en) 2010-05-20
KR20220112862A (ko) 2022-08-11
KR20170045385A (ko) 2017-04-26
US20240108657A1 (en) 2024-04-04
EP2358375A1 (en) 2011-08-24
CN103937737B (zh) 2023-05-23
KR101735125B1 (ko) 2017-05-15
NZ601862A (en) 2014-07-25
JP5974233B2 (ja) 2016-08-24
JP2016028578A (ja) 2016-03-03
CN103937737A (zh) 2014-07-23
KR20180097788A (ko) 2018-08-31
JP2012508691A (ja) 2012-04-12
KR20200138830A (ko) 2020-12-10
CN102271692B (zh) 2014-05-21
US8318484B2 (en) 2012-11-27
JP2021100428A (ja) 2021-07-08
NZ593207A (en) 2012-10-26
KR101893717B1 (ko) 2018-08-30
US20130149347A1 (en) 2013-06-13
KR20110100213A (ko) 2011-09-09
US10105392B2 (en) 2018-10-23
AU2017202897A1 (en) 2017-05-25
AU2019202099A1 (en) 2019-04-18
AU2019202099B2 (en) 2020-10-08
HK1197267A1 (zh) 2015-01-09
JP2023100876A (ja) 2023-07-19
EP2662440B1 (en) 2018-04-25
KR102357077B1 (ko) 2022-01-27
AU2009314552A1 (en) 2011-06-30
US9192629B2 (en) 2015-11-24
EP2662440A1 (en) 2013-11-13
WO2010056328A9 (en) 2011-05-19

Similar Documents

Publication Publication Date Title
HK1157190A1 (en) Isolated renal cells and uses thereof
WO2010088633A3 (en) Novel cell lines and methods
MX2011011402A (es) Sistemas, metodos y composiciones para optimizar injertos enriquecidos con celulas y tejidos.
WO2010096588A3 (en) Cell culture media containing combinations of proteins
WO2009055183A3 (en) Novel dyes
WO2011133902A3 (en) Cell culture medium comprising small peptides
NZ602201A (en) A novel ethanologenic clostridium species, clostridium coskatii
MX2010006169A (es) Enfoques moleculares para la optimizacion de la produccion de biocombustibles.
PL2174524T3 (pl) Ponowny wybór komórki w systemie komunikacji bezprzewodowej
WO2008122027A3 (en) Novel electrode
EP2264779A4 (en) Solar cell, solar cell string and solar cell module
WO2014015841A3 (zh) 一种利用微藻高效生产虾青素的方法
MX2009011956A (es) Metodos para detectar contaminantes organicos en la pulpa y fibra.
WO2010111659A8 (en) Tumor-initiating cells and methods for using same
WO2011056644A3 (en) Anti-glp-1r antibodies and their uses
WO2008118392A3 (en) Synthetic cell platforms and methods of use thereof
EP2786999A4 (en) SULFONATE COMPOUND, POLYMER ELECTROLYTE MEMBRANE COMPRISING SAME, AND FUEL CELL COMPRISING SAME
WO2009049274A8 (en) Microorganism engineered to produce isopropanol
EP2325896A4 (en) Front electrode for solar cell which minimizes power loss, and solar cell including the same
TN2010000270A1 (en) Process for the production of algal biomass with a high lipid content
WO2009102569A3 (en) Cell lines and methods for making and using them
BRPI0910122A2 (pt) "método de produção de biomassa de levedura"
WO2015004403A3 (fr) Procede de culture cellulaire decouple
WO2011059920A3 (en) Methods of generating neural stem cells
EP2343361A4 (en) CELL CULTURE KIT, SCREENING METHOD, AND METHOD FOR MANUFACTURING THE CELL CULTURE KIT